We are live on ! Find out more
CIA

Capital Impact Advisors Portfolio holdings

AUM $247M
1-Year Est. Return 31.15%
This Fund
S&P 500
This Quarter Est. Return
+10.5%
1 Year Est. Return
+31.15%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$284M
AUM Growth
+$21.7M
Cap. Flow
-$2.82M
Cap. Flow %
-0.99%
Top 10 Hldgs %
20.02%
Holding
124
New
5
Increased
32
Reduced
18
Closed
9

Top Buys

Rank Stock Value
1
VRSN icon
VeriSign
VRSN
+$2.67M
2
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$2.17M
3
SKX
Skechers
SKX
+$2.11M
4
ZM icon
Zoom
ZM
+$1.62M
5
HUBG icon
HUB Group
HUBG
+$1.02M

Sector Composition

Rank Sector Weight
1 Technology 31.06%
2 Healthcare 24.27%
3 Communication Services 10.05%
4 Consumer Discretionary 9.1%
5 Financials 7.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CORT icon
76
Corcept Therapeutics
CORT
$10.1B
$2.06M 0.72%
169,988
+7,444
+5% +$104K
EGRX
77
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$2.03M 0.71%
33,725
LOB icon
78
Live Oak Bancshares
LOB
$1.96B
$2.02M 0.71%
106,499
MPT
79
Medical Properties Trust
MPT
$2.89B
$2.02M 0.71%
95,849
CLR
80
DELISTED
CONTINENTAL RESOURCES INC.
CLR
$2.01M 0.71%
58,496
OKTA icon
81
Okta
OKTA
$23.9B
$1.99M 0.7%
17,235
STZ icon
82
Constellation Brands
STZ
$22.8B
$1.98M 0.7%
10,424
ALLO icon
83
Allogene Therapeutics
ALLO
$580M
$1.96M 0.69%
75,418
TTD icon
84
Trade Desk
TTD
$8.93B
$1.94M 0.68%
74,770
+1,230
+2% +$27.7K
RUN icon
85
Sunrun
RUN
$2.28B
$1.92M 0.68%
139,069
RARE icon
86
Ultragenyx Pharmaceutical
RARE
$2.5B
$1.89M 0.66%
44,133
WWE
87
DELISTED
World Wrestling Entertainment
WWE
$1.88M 0.66%
29,039
+4,515
+18% +$286K
SUPN icon
88
Supernus Pharmaceuticals
SUPN
$2.77B
$1.86M 0.66%
78,631
+2,866
+4% +$69.6K
WDAY icon
89
Workday
WDAY
$41B
$1.86M 0.65%
11,302
FDX icon
90
FedEx
FDX
$73.8B
$1.84M 0.65%
12,188
OMER icon
91
Omeros
OMER
$818M
$1.83M 0.65%
130,187
+24,372
+23% +$357K
XYZ
92
Block Inc
XYZ
$49.6B
$1.83M 0.65%
29,306
KURA icon
93
Kura Oncology
KURA
$808M
$1.82M 0.64%
132,344
+10,071
+8% +$149K
CNS icon
94
Cohen & Steers
CNS
$4.21B
$1.8M 0.63%
28,731
-8,368
-23% -$529K
EXEL icon
95
Exelixis
EXEL
$14B
$1.8M 0.63%
102,270
CSGP icon
96
CoStar Group
CSGP
$11.9B
$1.79M 0.63%
29,930
-6,780
-18% -$396K
AVLR
97
DELISTED
Avalara, Inc.
AVLR
$1.75M 0.62%
23,904
+9,139
+62% +$664K
AYX
98
DELISTED
Alteryx Inc
AYX
$1.74M 0.61%
17,395
+4,454
+34% +$453K
TWLO icon
99
Twilio
TWLO
$28.3B
$1.74M 0.61%
17,683
CCOI icon
100
Cogent Communications
CCOI
$600M
$1.72M 0.6%
26,076
-11,002
-30% -$664K

Similar funds

Capital Impact Advisors's Q4 2019 Portfolio in Review

As of Q4 2019, Capital Impact Advisors held 124 positions worth $284M, up 8.3% from $262M the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Capital Impact Advisors's Q4 2019 filing shows 5 new, 32 increased, 18 reduced and 9 closed positions. Its largest new stake was VeriSign: 14,212 shares worth $2.74M. The largest sale was Ollie's Bargain Outlet, an estimated $2.87M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 28% a quarter earlier, followed by Healthcare and Communication Services.

  • Capital Impact Advisors's largest Q4 2019 buy was VeriSign: 14,212 shares worth $2.74M.
  • Capital Impact Advisors added most to Guardant Health in Q4 2019, an estimated $842K increase.
  • Capital Impact Advisors's biggest Q4 2019 reduction was LendingTree, cutting an estimated $899K.
  • Capital Impact Advisors fully exited Ollie's Bargain Outlet in Q4 2019, selling an estimated $2.87M.
  • Capital Impact Advisors's ten largest holdings make up 20% of its $284M portfolio in Q4 2019.
  • Capital Impact Advisors opened 5 new positions and closed 9 in Q4 2019.
  • Capital Impact Advisors's portfolio value rose 8.3% quarter-over-quarter to $284M.

Based on Capital Impact Advisors's 13F filing for Q4 2019, filed 13 Feb 2020.